Department of Orthopaedic Surgery, College of Medicine, Ewha Womens University Seoul Hospital, Seoul, Republic of Korea.
Department of Orthopaedic Surgery, Seoul Metropolitan City Seonam Hospital, Seoul, Republic of Korea.
Arthroscopy. 2022 Apr;38(4):1089-1098. doi: 10.1016/j.arthro.2021.10.027. Epub 2021 Nov 10.
The purpose of this study is to report structural integrity and clinical outcomes of superior capsular reconstruction (SCR) using a 4- to 5-mm acellular dermal allograft combined with augmentation of the remaining rotator cuff to the graft.
We prospectively recruited 21 patients with symptomatic irreparable rotator cuff tear who required SCR. At least 6 months after the SCR, we evaluated each patient's graft healing by magnetic resonance imaging (MRI). We also assessed the range of motion (ROM), strength for forward flexion and external rotation, visual analog scale for pain (PVAS), American Shoulder and Elbow Surgeon (ASES) score, and Constant score. At minimum of 1 year after the surgery, we evaluated the number of patients with minimal clinically important differences (MCIDs) for each score to compare patients with healed and unhealed grafts.
Postoperative MRI showed the grafts intact in 14 patients (66.7%). Among 7 patients with unhealed grafts, tears were observed in 3 patients (42.9%) on the glenoid side, 3 (42.9%) on the humeral side, and 1 (14.3%) on both sides. PVAS, ASES score, and the Constant score improved after surgery (4.0 to 0.7 for PVAS [P < .001], 55.5 to 87.0 for ASES score [P < .001], and 56.0 to 65.9 for Constant score [P = .007]). However, there were no differences in postoperative ROM and muscle strength compared to preoperative measurements. MCIDs were reached in 90.5% of patients (n = 19) for the PVAS and in 71.4% of patients (n = 15) for the ASES score. Only 33.3% of patients (n = 7) obtained MCIDs for the Constant score, and none of the patients with a graft tear obtained MCIDs in the Constant score (P = .047).
The graft complete healing rate was 66.7%, although pain relief and functional improvement were satisfactory regardless of graft structural integrity. However, muscle strength recovery was not optimal until 1 year after surgery.
Level IV; case series.
本研究旨在报告使用 4-5mm 脱细胞真皮移植物对剩余肩袖进行增强,同时对肩袖进行重建(SCR)的结构完整性和临床结果。
我们前瞻性招募了 21 名需要 SCR 的症状性不可修复肩袖撕裂患者。在 SCR 后至少 6 个月,我们通过磁共振成像(MRI)评估每位患者的移植物愈合情况。我们还评估了运动范围(ROM)、前屈和外旋力量、疼痛视觉模拟量表(PVAS)、美国肩肘外科医生(ASES)评分和常数评分。在手术后至少 1 年,我们评估了每个评分中具有最小临床重要差异(MCID)的患者数量,以比较愈合和未愈合移植物的患者。
术后 MRI 显示 14 名患者(66.7%)的移植物完整。在 7 名未愈合移植物的患者中,3 名(42.9%)在肩胛侧、3 名(42.9%)在肱骨侧和 1 名(14.3%)在两侧观察到移植物撕裂。手术后 PVAS、ASES 评分和常数评分均有所改善(PVAS 从 4.0 降至 0.7[P<0.001],ASES 评分从 55.5 升至 87.0[P<0.001],常数评分从 56.0 升至 65.9[P=0.007])。然而,与术前测量相比,术后 ROM 和肌肉力量没有差异。90.5%的患者(n=19)PVAS 达到 MCID,71.4%的患者(n=15)ASES 评分达到 MCID。仅 33.3%的患者(n=7)常数评分达到 MCID,且无移植物撕裂的患者常数评分达到 MCID(P=0.047)。
尽管无论移植物结构完整性如何,疼痛缓解和功能改善都令人满意,但移植物完全愈合率为 66.7%。然而,直到手术后 1 年,肌肉力量恢复才达到最佳状态。
IV 级;病例系列。